Krka, d. d. (WSE:KRK)

Market Cap	26.16B
Revenue (ttm)	8.57B
Net Income (ttm)	1.70B
Shares Out	n/a
EPS (ttm)	55.56
PE Ratio	15.37
Forward PE	15.74
Dividend	35.03 (4.07%)
Ex-Dividend Date	Jul 22, 2025

Volume	120
Average Volume	76
Open	890.00
Previous Close	n/a
Day's Range	854.00 - 890.00
52-Week Range	586.00 - 990.00
Beta	0.42
RSI	50.32
Earnings Date	Jan 29, 2026

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription prod...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 11,308
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: KRK

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.

Financial numbers in EUR